Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

Autor: Lakhani, Nehal J, Chow, Laura Q M, Gainor, Justin F, LoRusso, Patricia, Lee, Keun-Wook, Chung, Hyun Cheol, Lee, Jeeyun, Bang, Yung-Jue, Hodi, Frank Stephen, Kim, Won Seog, Santana-Davila, Rafael, Fanning, Philip, Squifflet, Pierre, Jin, Feng, Kuo, Tracy C, Wan, Hong I, Pons, Jaume, Randolph, Sophia S *, Messersmith, Wells A
Zdroj: In The Lancet Oncology December 2021 22(12):1740-1751
Databáze: ScienceDirect